SCHEMBL3442175

SCHEMBL3442175

O=C(O)N1CCC(OCCN2CCC2)(c2cccnc2)CC1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
ALDH1A1 P00352 3/20 0.44
LMNA P02545 2/20 0.44
CHRNB2 P17787 1/20 0.43
CHRNA4 P43681 1/20 0.43
MAPK1 P28482 1/20 0.41
GAA P10253 2/20 0.40
PKM P14618 1/20 0.39
DRD2 P14416 2/20 0.39
DRD3 P35462 2/20 0.39
LTA4H P09960 1/20 0.38
CHRM2 P08172 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
TSHR P16473 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CCR5 P51681 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2333396 0.98 CHRNB2 (0.46) MEN1KMT2AALDH1A1LMNACHRNB2
SCHEMBL639657 0.92 CHRNB2 (0.43) MEN1KMT2AALDH1A1LMNACHRNB2
SCHEMBL3442182 0.91 CHRNB2 (0.44) MEN1KMT2AALDH1A1LMNACHRNB2
SCHEMBL3442371 0.86 MEN1 (0.47) MEN1KMT2AALDH1A1LMNAPKM
SCHEMBL4444695 0.86 MEN1 (0.44) MEN1KMT2AALDH1A1LMNACHRNB2
SCHEMBL4292955 0.86 NAMPT (0.46) CHRNB2CHRNA4TSHRCCR5
SCHEMBL4434546 0.85 MEN1 (0.43) MEN1KMT2AALDH1A1LMNACHRNB2
SCHEMBL3442554 0.84 MEN1 (0.43) MEN1KMT2AALDH1A1LMNACHRNB2
SCHEMBL3442414 0.84 MEN1 (0.42) MEN1KMT2AALDH1A1LMNACYP2D6
SCHEMBL3441655 0.84 MEN1 (0.42) MEN1KMT2AALDH1A1MAPK1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8318769-B2 Substituted sulfonamide compounds GRUENETHAL GMBH (DE) 2012-11-27 US disclosed
EP-2262792-A1 SUBSTITUTED SULFONAMIDE DERIVATIVES Grünenthal GmbH (DE) 2010-12-22 EP disclosed
US-20090264400-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2009-10-22 US disclosed
WO-2009124733-A1 SUBSTITUTED SULFONAMIDE DERIVATIVES GRUENENTHAL GMBH (DE) 2009-10-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264400-A1 Substituted Sulfonamide Compounds BDKRB1, BDKRB2, TRPV1 MEN1 2417/4885KMT2A 2533/4885ALDH1A1 1956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.